GENMAB AS DK 1 | 272.700 / -3.47% |
Date/Time | 03/03 / 12:35 |
Chg. / Chg.(%) | -9.800 / -3.47% |
Bid | 273.200 / 110 |
Ask | 273.400 / 110 |
Open | 278.300 |
Previous Close | 282.500 |
High | 278.300 |
Low | 272.500 |
Volume [EUR] | 23,359.600 |
Volume [Units] | 85 |
Price fixings | 10 |
ISIN | DK0010272202 |
Security | GE9 |
Exchange | TradeGate |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
Cboe Europe .. | 2,026.50 | ![]() |
28,922 |
Turquoise | 2,026.50 | ![]() |
8,083 |
London Inter.. | 2,036.0 | ![]() |
3,066 |
Cboe Europe .. | 2,028.50 | ![]() |
170 |
TradeGate | 272.700 | ![]() |
85 |
Cboe Europe .. | 2,045.00 | ![]() |
65 |
Frankfurt | 275.2000 | ![]() |
12 |
gettex | 272.600 | ![]() |
3 |
Vienna Globa.. | 278.20 | ![]() |
0 |
München | 284.70 | ![]() |
0 |
Düsseldorf | 272.40 | ![]() |
0 |
Berlin | 274.00 | ![]() |
0 |
Lang & Schwa.. | 272.20 | ![]() |
|
Stuttgart | 271.500 | ![]() |
|
OMX Nordic | 2,102.00 | ![]() |
189,102 |
Nasdaq Other.. | 338.2800 | ![]() |
372 |
Mexico | 7,638.15 | ![]() |
11,330 |
News
- Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
02/25/2021 / 20:53 - GlobeNewswire - Genmab announces initiation of share buy-back program
02/23/2021 / 17:05 - GlobeNewswire - Genmab Publishes 2020 Annual Report
02/23/2021 / 17:00 - GlobeNewswire - Genmab Announces Appointment of Tahamtan Ahmadi to Newly Created Position of Chief Medical Officer, Head of Experimental Medicines
02/22/2021 / 14:00 - GlobeNewswire - Genmab and Seagen Submit Tisotumab Vedotin Biologics License Application to the U.S. FDA for Patients with Recurrent or Metastatic Cervical Cancer
02/10/2021 / 22:05 - GlobeNewswire
Personal area
Click on
to activate push quotes.
